MétaCan
Menu
← Back to cohort
Record W4317538955 · doi:10.1093/cid/ciad019

Reply to Ito

2023· letter· en· W4317538955 on OpenAlexaff
John A. Staples, Dwight Ferris, Jason M. Sutherland

Bibliographic record

VenueClinical Infectious Diseases · 2023
Typeletter
Languageen
FieldMedicine
TopicAntibiotics Pharmacokinetics and Efficacy
Canadian institutionsCentre for Advancing Health OutcomesUniversity of British Columbia
Fundersnot available
KeywordsMedicineConfoundingAntimicrobialPropensity score matchingAdverse effectObservational studyEmergency medicineRandomized controlled trialIntensive care medicineInformation biasRetrospective cohort studyInternal medicineSelection bias

Abstract

fetched live from OpenAlex

To theEditor—We thank Dr Ito for thoughtful observations about our research and we appreciate the opportunity to respond [1]. In a matched retrospective observational cohort of 1842 patients, we found that patients receiving outpatient parenteral antimicrobial therapy (OPAT) had a similar number of adverse events and lower direct healthcare costs than patients receiving inpatient parenteral antimicrobial therapy (IPAT) [2]. Dr Ito highlights that unobserved differences in treatment adherence might have influenced our findings [1]. We believe that this raises two related but distinct issues. First, hospitalized patients receiving IPAT have intravenous antimicrobials directly administered by nurses. In contrast, community-based patients receiving OPAT plausibly face more logistical barriers (eg, missed appointments and homecare visits, undelivered drugs, or venous access malfunction) that result in delayed, incomplete, or omitted antimicrobial doses. In a randomized trial, these factors might reduce antimicrobial adherence and produce less favorable outcomes among these patients. Second, physicians in clinical practice do not randomly allocate patients to OPAT or IPAT. Real-world outcomes might appear better with OPAT because physicians selecting patients for outpatient care probably “cherry-pick” the healthiest and most treatment-adherent patients who already have a better-than-average prognosis [3]. We used matching and adjustment to account for prognostically important baseline differences between OPAT and IPAT patient groups in our study, but our adjusted effect estimates are still subject to bias from residual confounding [2]. This remains a previously acknowledged limitation of our study. Our results nonetheless suggest that OPAT is a safe and effective choice for appropriately selected patients. The substantial cost savings arising from the transition from IPAT to OPAT should be reallocated to support adherence and expand delivery of OPAT in the community [4]. Author contributions. All authors were responsible for drafting and revising this reply. Disclaimer. Funding organizations were not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review and approval of this manuscript. Financial support. The original study was supported by an unrestricted grant from the British Columbia Infectious Diseases Society. J. A. S. was supported by the Vancouver Coastal Health Research Institute and by a health professional­–investigator award from Michael Smith Health Research BC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.066
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.019
Threshold uncertainty score0.060

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0050.066
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.001
Science and technology studies0.0030.003
Scholarly communication0.0050.006
Open science0.0030.004
Research integrity0.0190.037
Insufficient payload (model declined to judge)0.0180.011

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.072
GPT teacher head0.418
Teacher spread0.346 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueClinical Infectious Diseases→Same topicAntibiotics Pharmacokinetics and Efficacy→French-language works237,207→